BOB体育

Skip to main content

Christopher Harden, MD : Research

Critical Care Medicine Specialist, Pulmonologist (Lung Specialist)

Photo of Christopher Harden

Active clinical trials

RESOLVE - Lung

This is a randomized, double-blind, placebo-controlled study with an open-label extension (OLE).

Investigators
Christopher Harden, Divya C Patel
Status
Accepting Candidates
Ages
18 Years - N/A
Sexes
All
Efficacy and Safety of BMS-986278 in Pulmonary Fibrosis

The purpose of this study is to provide an initial evaluation of the effectiveness of BMS-986278 in participants with lung fibrosis, to demonstrate the safety of BMS-986278, and provide information on the drug levels of BMS-986278 in these鈥�

Investigator
Christopher Harden
Status
Accepting Candidates
Ages
21 Years - N/A
Sexes
All

My publications

4 publications

2021

A 60-Year-Old Man With Dyspnea, Proximal Muscle Weakness, and Pulmonary Arterial Hypertension.

Chest

鈥�

2021

Response.

Chest

鈥�

2020

Systemic Capillary Leak Syndrome Secondary to Coronavirus Disease 2019.

Chest

鈥�

2017

Stop Being So Sensitive: An Exceptionally Rare Report of Ustekinumab-Induced Sub-acute Hypersensitivity Pneumonitis.

Turkish journal of anaesthesiology and reanimation

鈥�